MATCH SIZE AND QUANTITY
Build your comparison.
Choose a labeled amount and selection to load matching prices.
Flawless Compounds
44 products · 62 listings
Daily snapshot · inspect sources
Vial comparison
Eloralintide prices
Compare Eloralintide listings by strength, selection and supplier. Inspect the original source behind each price.
4suppliers represented
4source-linked listings
1strengths available
GO BEYOND THE PRICE
Track it. Plan it. Inspect it.
Select a strength and selection above to view price history, save a price watch or add it to your basket.
DOCUMENTATION PASSPORTS
Reports and batch records
Inspect the source report, recorded lot and document access. A report link does not confirm the batch currently shipping.
Loading documentation records…
Listed amounts and selections
- 10 mg4 suppliers · Pack counts: 1
Reported quantities in this family: 1. Counts and units must be matched to the exact listing.
Compare the exact selection
Choose the labeled amount per unit and quantity before comparing. A single unit and a multipack have different upfront prices. Keep product format and exact recipe consistent; similar names do not establish equivalent products.
Follow the original listing to check its quantity, availability and current price. Unit prices use the full labeled mass in each selection.
Single-vial price overview
Compare within each strength. Every row covers one vial and includes only listings marked in stock with known quantities.
| Strength | Selection | Lowest listed total price | Price per mg | Supplier count | Compare |
|---|---|---|---|---|---|
| 10 mg | 1 vial | $136.00 | $13.60 | 4 | Compare |
Suppliers with Eloralintide listings
4 profiles
Glow Aminos
29 products · 39 listings
Platinum Lion
37 products · 56 listings
Southern Aminos
39 products · 51 listings
Sources and comparison limits
0 listings from direct supplier captures and 4 listings from aggregator reports. Capture and import dates record when data was obtained; they do not guarantee the supplier’s current price or stock.
Listings include out-of-stock and unconfirmed-stock records. Inclusion does not certify a supplier, a batch or a product. Read how matching and source dates work.
Explore more vial listings
FROM PEPTIDES CALCULATOR
About Eloralintide
Source profile reviewed 2026-10-02 · Imported 2026-10-22. Read the full compound profile
Eloralintide (LY3841136) is an investigational long-acting peptide that selectively activates the amylin receptor, the satiety pathway used by the pancreatic hormone amylin that is released alongside insulin after meals. The sponsor dosed it once weekly by subcutaneous injection in a 48-week Phase 2 trial published in The Lancet in November 2025, where fixed doses of 1-9 mg produced 9-20% weight loss against 0.4% with placebo, and Phase 3 trials are under way. It is not approved anywhere and has never been sold as a medicine; PubChem carries a record for it with no defined stereochemistry and no published full sequence, and research vendors sell it as a 10 mg lyophilized vial.
- Formula
- C201 H319 N49 O65 S2
- Molar mass
- 4,526 g/mol
- CAS number
- 2883634-40-8
Research evidence described in the source
Human studies and registrations
4 protocol rows on this page come from human trials, trial registrations, regulator labels or reviews of human data. Approval status and populations are stated per row.
Community-reported use
2 rows record what blogs, vendor write-ups or forums describe for Eloralintide. None has been verified against primary literature.
Limitations noted in the source
- Every amount on this page is a report of what a source describes, not a protocol to follow.
- Preclinical and community rows do not establish a human amount, schedule or route.
- Formulation, purity and presentation vary by supplier and are not covered by the dossier.
Publications and references linked by the source
Background is reproduced from Peptides Calculator with attribution. The source describes compound-level research. It does not evaluate the identity, quality or suitability of a listed supplier’s product or batch.